You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 274 Tumoral and peripheral immunophenotype of refractory vs relapse to PD-(L)1 blockade in patients with advanced non-small cell lung cancer

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials completed
274 Tumoral and peripheral immunophenotype of refractory vs relapse to PD-(L)1 blockade in patients with advanced non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020179029
Dec 20201805
Jan 20212807
Feb 20211804
Mar 20212207
Apr 20211203
May 2021706
Jun 2021004
Jul 20210011
Aug 2021005
Sep 2021005
Oct 202130026
Nov 202140011
Dec 20212003
Jan 20222802
Feb 20221203
Mar 20222001
Apr 20224802
May 20221601
Jun 20221802
Jul 20221201
Aug 20222003
Sep 2022130015
Oct 20223003
Nov 20221602
Dec 20222000
Jan 20232000
Feb 20233201
Mar 20231800
Apr 20231402
May 20231000
Jun 20231201
Jul 2023802
Aug 20231001
Sep 2023200
Oct 20232004
Nov 20233204
Dec 20233001
Jan 2024800
Feb 20242800
Mar 20243001
Apr 2024401
May 20241603
Jun 20242800
Jul 20242803
Aug 20241401
Sep 20241602
Oct 20242403
Nov 20241601
Dec 2024805
Jan 20252206
Feb 2025001
Mar 2025005
Apr 2025003
May 2025004
Jun 2025005
Total11940221